Literature DB >> 29037905

The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature.

A Rigon1, M Infantino2, M Merone3, G Iannello3, A Tincani4, I Cavazzana5, N Carabellese5, A Radice6, M Manfredi2, P Soda3, A Afeltra7.   

Abstract

Recently there has been an increase demand for Computer-Aided Diagnosis (CAD) tools to support clinicians in the field of Indirect ImmunoFluorescence (IIF), as the novel digital imaging reading approach can help to overcome the reader subjectivity. Nevertheless, a large multicenter evaluation of the inter-observer reading variability in this field is still missing. This work fills this gap as we evaluated 556 consecutive samples, for a total of 1679 images, collected in three laboratories with IIF expertise using HEp-2 cell substrate (MBL) at 1:80 screening dilution according to conventional procedures. In each laboratory, the images were blindly classified by two experts into three intensity classes: positive, negative, and weak positive. Positive and weak positive ANA-IIF results were categorized by the predominant fluorescence pattern among six main classes. Data were pairwise analyzed and the inter-observer reading variability was measured by Cohen's kappa test, revealing a pairwise agreement little further away than substantial both for fluorescence intensity and for staining pattern recognition (k=0.602 and k=0.627, respectively). We also noticed that the inter-observer reading variability decreases when it is measured with respect to a gold standard classification computed on the basis of labels assigned by the three laboratories. These data show that laboratory agreement improves using digital images and comparing each single human evaluation to potential reference data, suggesting that a solid gold standard is essential to properly make use of CAD systems in routine work lab.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-nuclear antibodies; Computer-Aided Diagnosis; Hep-2; Indirect ImmunoFluorescence; Inter-observer variability

Mesh:

Substances:

Year:  2017        PMID: 29037905     DOI: 10.1016/j.autrev.2017.10.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  6 in total

1.  Retrospective analysis of infectious laryngotracheitis in backyard chicken flocks in California, 2007-2017, and determination of strain origin by partial ICP4 sequencing.

Authors:  Julia Blakey; Simone Stoute; Beate Crossley; Aslı Mete
Journal:  J Vet Diagn Invest       Date:  2019-04-11       Impact factor: 1.279

2.  A Multicenter Analysis of Subjectivity of Indirect Immunofluorescence Test in Antinuclear Antibody Screening.

Authors:  Vildan Turan Faraşat; Talat Ecemiş; Yavuz Doğan; Aslı Gamze Şener; Gülfem Terek Ece; Pınar Erbay Dündar; Tamer Şanlidağ
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

3.  Think autoimmunity, breath autoimmunity, and learn autoimmunity.

Authors:  Elias Toubi; Zahava Vadasz
Journal:  Clin Rheumatol       Date:  2019-04-12       Impact factor: 2.980

Review 4.  Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems.

Authors:  Luigi Cinquanta; Nicola Bizzaro; Giampaola Pesce
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 5.  Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges.

Authors:  Andrew McLean-Tooke; Irene Moore; Fiona Lake
Journal:  Clin Transl Immunology       Date:  2019-11-05

6.  Evaluation of a Fully Automated Antinuclear Antibody Indirect Immunofluorescence Assay in Routine Use.

Authors:  Hyun-Woo Choi; Yong Jun Kwon; Ju-Heon Park; Seung-Yeob Lee; Sejong Chun; Eun Jeong Won; Jun Hyung Lee; Hyun-Jung Choi; Soo Hyun Kim; Myung-Geun Shin; Jong-Hee Shin; Seung-Jung Kee
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.